Gabapentin Market Outlook:
Gabapentin Market size was over USD 2.56 billion in 2025 and is projected to reach USD 4.41 billion by 2035, growing at around 5.6% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of gabapentin is evaluated at USD 2.69 billion.
The growth of the market can be propelled by the increasing number of people suffering from epilepsy. Since, gabapentin belongs to the family of anticonvulsants it is prescribed to control seizures in individuals with epilepsy. As per a report by World Health Organization, globally 5 million people suffer from epilepsy with an LMC diagnosis rate in epilepsy 139 per 100,000 people.
Another one of the biggest growth drivers boosting the market expansion is the high utilization of gabapentin as a pain management drug, especially during neuropathic pain. This is largely attributable to an increase in chronic pain for illnesses such as diabetic neuropathy, spinal injuries, and shingles, which are difficult to treat with opioids. In 2021, an estimated 20.9% of U.S. adults experienced chronic pain, and 6.9% of adults experienced high-impact chronic pain.
